Products

XD BIOCHEM's broad and integrated portfolio of services enables our customers and partners in the pharmaceutical, biotech and medical device industries worldwide to research, develop, discover and produce innovative healthcare products quickly and effectively.

XD BIOCHEM offers its diverse array of customers access to a wide range of capabilities and services, allowing all to develop new medicines at any phase of R&D. This integrated, open-access platform helps lower the barriers of R&D and expedite the delivery of new medicines to patients globally.

XD BIOCHEM Provides CRDMO services for new drug development from discovery to commercial, meeting any material requirement at any scale and covering all categories for all synthetic molecular modalities, including small molecules, oligonucleotides, peptides and complex conjugates

Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic.

Small Molecule (CRDMO)
End-to-End CRDMO Platform for Small Molecule

Drug R&D and Medical Device Testing
Comprehensive, integrated services to get solutions from platform to patient

Clinical Research Services
Comprehensive Phase I-IV clinical development services

Oligonucleotide (CRDMO)
End-to-End CRDMO Platform for Oligonucleotide

Peptide (CRDMO)
End-to-End CRDMO Platform for Peptide

Cell Therapy and Gene Therapy
Solutions to develop tomorrow's life-changing advanced therapies